Already, however, the new rule may be having a chilling effect. Despite years of annual growth in the number of foreign-born applicants to U.S. physician training programs, 2025 has seen a nearly 10% ...
Calgary Herald on MSN
Calgary municipal election 2025: Voters' guide for councillor candidates
With election day for the 2025 civic general election looming on Oct. 20, there are more than 70 people running for ...
The world is more connected than ever, and the desire to explore new places for work or study is growing. PR Global ...
International students seeking to work in Canada after graduation face new challenges with the Post-Graduation Work Permit.
OTTAWA (ANI) – One of the suspects in the killing of Sikh separatist leader Hardeep Singh Nijjar, has said in a social media video that he entered Canada on a ‘study permit’ which only took him days ...
In 2025, only 30% of international students received study permit approvals in Canada, marking a steep decline driven by abrupt policy shifts, administrative delays, and systemic challenges. Shrinking ...
Canada’s immigration system has entered a new update cycle, with Immigration, Refugees and Citizenship Canada (IRCC) releasing its latest processing times as of October 1, 2025. These changes affect ...
PARIS - People who are diagnosed with autism later in life could have a different form of the condition than those diagnosed during childhood, a large study said on Oct 1. The findings come as US ...
This Guide provides non-Canadians with an introduction to the laws and regulations that affect the conduct of business in Canada and, in ...
JEE Main Registration Form 2026: The National Testing Agency (NTA) is set to release the JEE Main 2026 Application Form in October 2025. The official website for registration, jeemain.nta.nic.in, is ...
Canada’s stricter visa and study permit regulations are sparking growing anxiety among international students — particularly Indians — who once viewed the country as a stable gateway to education and ...
Skye Bioscience’s obesity candidate has failed to reduce weight in a phase 2 study, marking another setback for the CB1 inhibitor class. The biotech had been evaluating a 200-mg weekly subcutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results